1207 / 1631
Nodal MZL
•
<2% NHL median age 60
•
Upto 30% have Hep C + serology (variable)
•
Generalised asymptomatic LN;
•
BM in 30-60%..exclude dissemination of
ENMZL
•
Few therapeutic trials – same principles as
other ‘indolent’ lymphomas..watch and wait
•
60-80% alive at 5 years